Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty
- Conditions
- Urethral Stricture, Male
- Interventions
- Drug: Standard Buccal HarvestDrug: Basic buccal procedure + Long acting localDrug: Basic buccal procedure + Buccal block
- Registration Number
- NCT05300685
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
Patients undergoing buccal urethroplasty will often have significant post-operative oral pain from the graft site. Various graft harvest techniques and methods for post-harvest hemostasis including graft site closure have been explored. Despite the frequency of this clinical scenario there is no established best practice for peri-operative pain management in this patient population. In addition to traditional post operative pain control, groups have sought various peri-operative anesthetic regimens to improve post operative pain. This has led recently to the description of various regional blocks including buccal and periorbital blocks for peri-operative local anesthetic. No study has looked at superiority of regional pain management in this patient population. This study will aim to assess three established anesthetic protocols for oral pain control in a blinded, randomized controlled trial.
Hypothesis: Patients who have buccal block will have lower post op pain without any increase adverse oral outcomes.
- Detailed Description
This is a blinded, randomized, controlled trial following patients undergoing buccal urethroplasty (see criteria). This study will aim to assess three established anesthetic protocols for oral pain control. Each study arm holds equal weight. Approximately 60 subjects will be randomized in a 1:1:1 ratio to receive the following graft harvest techniques, which are all considered standard of care.
Group 1: Current Buccal Harvest
* Infiltration of lidocaine 1% with 1:100,000 epinephrine (maximum 10cc)
* Graft site hemostasis with monopolar cautery
* No suture closure of graft site
Group 2: Basic buccal procedure + Long acting local
* Infiltration of lidocaine 1% with epinephrine (maximum 10cc)
* Graft site hemostasis with monopolar cautery
* No suture closure of graft site
* 0.5% Marcaine (maximum 5cc) at case conclusion
Group 3: Basic buccal procedure + Buccal block
* Infiltration of lidocaine 1% with epinephrine (maximum 10cc)
* Graft site hemostasis with monopolar cautery
* No suture closure of graft site
* Buccal block with 0.5% Marcaine (maximum 5cc) at case conclusion
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 60
- Men, age 18 or older
- Undergoing anterior urethroplasty with buccal grafting
- Able to consent
- Taking chronic opiates for pain
- Diagnosis of chronic pain
- Prior buccal urethroplasty
- Vulnerable population (e.g. prisoner)
- Renal dysfunction or allergy preventing NSAID use
- Liver dysfunction or allergy preventing Tylenol use
- Medical allergy to local anesthetic
- Medical allergy to Peridex/Magic Mouthwash
- NYHA Class III/IV
- Hematologic condition that excludes patient from surgery
- Post-operative complication resulting in inpatient stay
- Anesthetic complication
- No buccal site surgical complication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 1: Standard of care Standard Buccal Harvest 1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. No further infiltration of local anesthetic in mouth Group 2: Standard of care + Long acting local Basic buccal procedure + Long acting local 1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration in the buccal graft site Group 3: Standard of care + Buccal block Basic buccal procedure + Buccal block 1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration as a buccal block
- Primary Outcome Measures
Name Time Method Change(s) in Post-operative pain Postoperative Day 1, 5, 10 The Wong-Baker FACES pain scale is a validated scale where a score of 0 is no pain and 10 is the worst pain imaginable. Pain greater than or equal to 5 would result in significant limitations on daily life.
Oral, incisional (surgical site), and overall pain will each be assigned a score of 0-10 at each time point (9 total scores).
- Secondary Outcome Measures
Name Time Method Change(s) in Post-operative Narcotic use Postoperative Day 1, 5, 10 Patient measure of number of oxycodone tablets taken (0-5). Patient request for additional narcotic medicaiton (Yes/No) Patient measure of adherence to non-narcotic pain regiman (Yes/No)
Trial Locations
- Locations (2)
University of California San Francisco
🇺🇸San Francisco, California, United States
MedStar Urology
🇺🇸Washington, District of Columbia, United States